Mobile
Calendar
Contact & About
Directions & Maps
Employment
Staff Login
All MCW
Department Only
Education
Education at MCW
- Medical School
- Central Wisconsin and Green Bay Campuses
- Graduate School of Biomedical Science
- Residencies & Fellowships (GME)
- Postdoctoral Education
- Continuing Medical Education (CME)
- Teaching Toolbox
Patient & Public Health
MCW Libraries
Advancing a Healthier Wisconsin
Research
Research at MCW
Office of Research
MCW Libraries
Research Centers
Core Facilities/Research Resources
Technology Transfer
Research Education & Training
CTSI
eBridge Support
Advancing a Healthier Wisconsin
Faculty Collaboration Database
Patient Care
Patient Care at MCW
Hospitals & Clinics
Find a Doctor
Public & Community Health
Clinical & Medical Departments
Centers, Institutes, Special Programs
Health Information
MyChart Online Health Record
Health Calculators
Billing Services for Patients
Best Doctors in America
Community Health
Community Engagement at MCW
Institutional & Community Engagement
Advancing a Healthier Wisconsin
Healthier Wisconsin Partnership Program
Community Partnerships
Medical Departments & Centers
Find a Doctor
Health Information
Departments
All Departments Alpha List
- Academic Departments & Divisions
- Medical Departments & Divisions
- Basic Science Departments
- Centers, Institutes, Special Programs
- Administrative & Support Departments
Career Opportunities - Jobs@MCW
News & Events
Phone Numbers & Addresses
Give to MCW
Giving Options
Tax-Wise Giving
Give Now - Donate online
Giving Contacts & Phone Numbers
Neurology
www.mcw.edu
>
Neurology
>
Research
>
Research Labs
>
Current Whelan Laboratory Research
Email
|
Bookmark
|
RSS
|
Print
About/Contact
Chair's Message
Best Doctors 2011
Contact Us
Schedule an Appointment
How to Find Us
Divisions
Adult Neurology
Pediatric Neurology
Neuropsychology
Neurointervention
Faculty
Piero G. Antuono, MD
Paul E. Barkhaus, MD
Humberto A. Battistini, MD
Jeffrey R. Binder, MD
Karen A. Blindauer, MD
Julie A. Bobholz, PhD
Diane S. Book, MD
Christopher R. Butson, Ph.D.
Thomas C. Chelimsky, MD
Michael Collins, MD
Lisa L. Conant, PhD
Jennifer M. Connelly, MD
Carol A. Everson, PhD
Brian-Fred Fitzsimmons, MD
Jonathan Florczak, MD
Malgorzata B. Franczak, MD
Jennifer Geiger, PhD
Gregory J. Harrington, MD
Kurt Hecox, MD, PhD
Amy K. Heffelfinger, PhD
Ann Helms, MD
Bradley C. Hiner, MD
Chamindra Konersman, MD
Jennifer I. Koop, PhD
Marc A. Lazzaro, MD
Einat Liebenthal, DSc
John Lynch, MD
Mark G. Malkin, MD
Jorge Marquez de Leon, MD
Michael McCrea, PhD
Robert F. Newby, PhD
Wendy L. Peltier, MD
Tom Prieto, PhD
Manoj Raghavan, MD, PhD
Linga Reddy, MD, PhD
Bernd F. Remler, MD (Chief)
Merav Sabri, PhD
David S. Sabsevitz, PhD
Michael J. Schwabe, MD
John Skantz, MD
Kristin Smith, PhD
Katie Spangler, MD
Sara J. Swanson, PhD
Harry T. Whelan, MD
Mary Yellick, RN MSN, APNP
Sam O. Zaidat, MD
Patient Resources
Support Groups
Clinical Specialty Programs
Find a Doctor
Schedule an Appointment
Research
Research In Neurology
Pediatric Research
Research Labs
Clinical Trials
Graduate Education
Postdoctoral Research in Functional Imaging
Neuroscience Doctoral Program
Residents & Fellows
Adult Neurology Residency
Pediatric Neurology Fellowship
Internal Medicine-Neurology Combined Residency
Autonomic Disorders Fellowship
Neurocritical Care Fellowship
Endovascular Surgical Neuroradiology Fellowship
Clinical Neurophysiology Fellowship
Neurointervention Fellowship
Neuropsychology Fellowship
Vascular Neurology Fellowship
Current Whelan Laboratory Research
"Cerebral Oxygen Saturation in Children with Epilepsy: A Pilot Study"
This is a pilot study that aims to address the relationship of regional cerebral oximetry, measured using near-infrared spectroscopy, with seizure activity in the periictal period in children with epilepsy. The following hypotheses will be tested: 1. Regional cerebral saturation of oxygen will increase prior to the onset of seizure activity; 2. Regional cerebral saturation of oxygen will have a carried response during seizure activity depending on the seizure type; 3. Regional cerebral saturation of oxygen will return to baseline following cessation of seizure activity.
"Amelioration Of Oral Mucositis Pain By NASA Near Infra Red Light Emitting Diodes In Bone Marrow Transplant Patients: a Randomized Multi-Center Controlled Clinical Trial"
The aim of this project is to investigate the use of extra-orally applied near infra-red (NIR) phototherapy for the reduction of oral pain secondary to chemo- and radiation-therapy-induced mucositis in adult and pediatric hematopoietic stem cell transplant (HSCT) patients.
"Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study"
NIR-LED treatment promotes retinal healing and improves visual function following high intensity laser retinal injury by augmenting cellular energy metabolism, enhances mitochondrial function, increases cytochrome C oxidase activity, stimulates antioxidant protective pathways, and promotes cell survival. LED therapy has been approved as a non-significant risk (NSR) device for treatment of eye disorders, has a low treatment cost, and may serve as an effective, non-invasive alternative or adjunctive treatment to laser photocoagulation, the current standard of care for diabetic macular edema. The aims of this projects are to determine the effects of short term (3 month) NIR-LED therapy on anatomic and functional abnormalities of diabetic macular edema as assessed by visual acuity, optical coherence tomography, and fundus biomicroscopy.
"Near-infrared light-emitting diode (NIR-LED) therapy for Leber’s Hereditary Optic Neuropathy (LHON)"
The overall objective of this project is to test the hypothesis that NIR-LED therapy will stimulate mitochondrial function, attenuate oxidative stress, and improve cell survival and vision in subjects with LHON.
"Photodynamic Therapy (PDT) for Brain Tumor Dispersal"
This project examines the hypothesis that patients with progressive/recurrent malignant brain tumors undergoing PDT with Photofrin will show a dose dependent improvement in free survival and overall survival outcomes. PDT will also be effective against infratentorial tumors and in pediatric patients. The protocol will establish the maximum tolerable dose of Photofrin in adults and in children using a dose-escalation scheme, then measure effectiveness trends at one-year and two-year post-PDT time points.
webmaster@mcw.edu
© 2013 Medical College of Wisconsin
Education
|
Research
|
Patient Care
|
Community Health
|
Departments
|
Staff Login
MCW Home
|
Mobile
|
Contact
|
Calendar
|
Directions/Maps
|
Terms & Privacy | About this Web Site
|
Site Map
Page Updated 08/03/2012